Overview

Multiple Ascending Doses of AMG 570 in Subjects With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2020-06-12
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety and tolerability of AMG 570 following multiple dose administration in subjects with rheumatoid arthritis (RA). A study to characterize the pharmacokinetic profile of AMG 570 following multiple dose administration in subjects with RA. Hypothesis: Multiple dose administration of AMG 570 will have acceptable safety and tolerability profiles in RA subjects within the proposed dose range.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen